Sanofi S.A. ADR diskutieren
Sanofi S.A. ADR
WKN: 662283 / Symbol: SNY / Name: Snof / Aktie / Pharmazeutika / Large Cap /
48,20 €
-1,63 %
Sanofi (NASDAQ: SNY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NASDAQ: SNY) had its price target raised by analysts at Argus from $55.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for SNY provided by MarketBeat
Sanofi (NASDAQ: SNY) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "sell" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NYSE: SNY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NYSE: SNY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NYSE: SNY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NYSE: SNY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NYSE: SNY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NYSE: SNY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NASDAQ: SNY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NASDAQ: SNY) was upgraded by analysts at Berenberg Bank from a "hold" rating to a "buy" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NASDAQ: SNY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NASDAQ: SNY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NASDAQ: SNY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for SNY provided by MarketBeat
Sanofi (NASDAQ: SNY) had its price target raised by analysts at Argus from $55.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for SNY provided by MarketBeat
Neueste Beiträge
Needham___Company_LL in Biogen Inc. diskutieren